MRA Advisory Group’s Cardinal Health CAH Stock Holding History

MRA Advisory Group’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,856	Closed	-$270K	–	124
2023 Q2	$270K	Sell	2,856 -421	-13%	-$35.6K	0.19%	97
2023 Q1	$247K	Buy	+3,277	New	+$247K	0.18%	102

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MRA Advisory Group's CAH Position: Q3 2023 in Review

MRA Advisory Group sold out of Cardinal Health (CAH) in Q3 2023, closing a stake of 2,856 shares — an estimated $270K sold.

MRA Advisory Group first reported a position in CAH in Q1 2023 and held it in 2 quarters. The position peaked at $270K in Q2 2023. 948 funds tracked by Wall St. Rank hold CAH as of Q3 2023.

MRA Advisory Group reported no remaining Cardinal Health position as of Q3 2023 after selling out during the quarter.
MRA Advisory Group sold 2,856 Cardinal Health shares in Q3 2023, an estimated $270K.
MRA Advisory Group first reported a position in Cardinal Health in Q1 2023 and held it in 2 quarters.
MRA Advisory Group's Cardinal Health position peaked at $270K in Q2 2023.
948 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2023.

Based on MRA Advisory Group's 13F filing for Q3 2023, filed 8 Nov 2023.